前往化源商城
入驻化源商城

品牌现货直购
供应商:我要出现这里





查看所有供应商和价格请点击:

87344-06-7生产厂家

87344-06-7价格

87344-06-7

87344-06-7结构式
87344-06-7结构式
  • 常用中文名:呱氨托美丁
  • 常用英文名:Amtolmetin guacil
  • CAS号:87344-06-7
  • 分子式:C24H24N2O5
  • 分子量:420.458
  • 相关类别: 信号通路 G 蛋白偶联受体/G 蛋白 前列腺素受体
  • 发布时间:2018-06-22 22:34:05
  • 更新时间:2024-01-02 12:36:58
  • 氨甲喋呤-瓜氨酸是一种有效的非甾体抗炎药,具有镇痛作用。Amtolmetin guacil抑制前列腺素合成和环氧合酶(COX)。Amtolmetin guacil可以刺激胃肠道壁上的辣椒素受体,并释放胃保护性一氧化氮(NO)。Amtolmetin guacil可用于研究膝关节骨关节炎[1][2]。

化源商城直购

中文名 哌氨托美丁
英文名 2-Methoxyphenyl 2-(2-(1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl)acetamido)acetate
中文别名 2-甲氧苯基 2-(1-甲基-5-(4-甲基苯甲酰)-1H-吡咯-2-乙酰氨基乙酸酯
呱氨托美丁
英文别名 2-Methoxyphenyl N-{[1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetyl}glycinate
amtolmetin guacil
Glycine, N-[2-[1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetyl]-, 2-methoxyphenyl ester
MFCD00866153
描述 氨甲喋呤-瓜氨酸是一种有效的非甾体抗炎药,具有镇痛作用。Amtolmetin guacil抑制前列腺素合成和环氧合酶(COX)。Amtolmetin guacil可以刺激胃肠道壁上的辣椒素受体,并释放胃保护性一氧化氮(NO)。Amtolmetin guacil可用于研究膝关节骨关节炎[1][2]。
相关类别
靶点

Prostaglandin receptor, COX, NO[1][2]

体外研究 在大鼠新鲜血浆和大鼠肝微粒体中,氨甲酰胍(100μM;0-60分钟)与MED5(1-甲基-5-对甲基苯甲酰基-吡咯-2-乙酰氨基乙酸)一起转化为TMT(托尔梅汀,HY-B1799),快速转化为MED5和MED5甲酯,而在人新鲜血浆和人肝微粒体内不产生TMT[3]。
体内研究 动物模型:雄性Wistar大鼠[3]剂量:50 mg/kg给药:p.o。;单剂量结果:Amtolmetin guacil在雄性Wistar大鼠体内的药代动力学参数[3]。AUC0-t(ng/mL·h)AUC0-∞ (ng/mL·h)Cmax(μg/mL)Tmax(h)Kel(h-1)t1/2,β
密度 1.2±0.1 g/cm3
沸点 663.3±55.0 °C at 760 mmHg
熔点 117-120ºC
分子式 C24H24N2O5
分子量 420.458
闪点 354.9±31.5 °C
精确质量 420.168518
PSA 86.63000
LogP 1.98
外观性状 白色针状晶体
蒸汽压 0.0±2.0 mmHg at 25°C
折射率 1.583
储存条件 室温,干燥
Material Safety Data Sheet

Section1. Identification of the substance
Product Name: Amtolmetin guacil
Synonyms:

Section2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section3. Composition/information on ingredients.
Ingredient name:Amtolmetin guacil
CAS number:87344-06-7

Section4. First aid measures
Skin contact:Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact:Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation:Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion:Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution:Wear approved mask/respirator
Hand precaution:Wear suitable gloves/gauntlets
Skin protection:Wear suitable protective clothing
Eye protection:Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section7. Handling and storage
Handling:This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section9. Physical and chemical properties
Appearance:Not specified
Boiling point:No data
No data
Melting point:
Flash point:No data
Density:No data
Molecular formula:C24H24N2O5
Molecular weight:420.5

Section10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section11. Toxicological information
No data.

Section12. Ecological information
No data.

Section13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section14. Transportation information
Non-harzardous for air and ground transportation.

Section15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

CHEMICAL IDENTIFICATION

RTECS NUMBER :
MC0598400
CHEMICAL NAME :
Glycine, N-((1-methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl)acety l)-, 2-methoxyphenyl ester
CAS REGISTRY NUMBER :
87344-06-7
LAST UPDATED :
199512
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C24-H24-N2-O5
MOLECULAR WEIGHT :
420.50

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1450 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BAXXDU British UK Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #2115417
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BAXXDU British UK Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #2115417
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>1500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BAXXDU British UK Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #2115417
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1370 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BAXXDU British UK Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #2115417

危害码 (欧洲) Xi